2021 Global Respiratory Syncytial Virus (RSV) Diagnostics Market Shares, Segmentation Forecasts, Competitive Landscape, Innovative Technologies , Latest Instrumentation, Opportunities for Suppliers
This unique report from LeadingMarketResearch.com provides information and analysis not available from any other published source.
The report is available by section, and can be customized to specific information needs and budget.
The report presents a detailed analysis of the Respiratory Syncytial Virus diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Respiratory Syncytial Virus definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: Hospitals, Commercial/Private Labs, Physician Offices, Public Health Labs
For each country, in addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of Respiratory Syncytial Virus tests.
Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns.
Contains 227 pages and 15 tables
II. Worldwide Test Overview,
Technologies and Instrumentation
A. Background, Diagnostic Tests, Vaccines and Drugs
B. Instrumentation Review: Operating Characteristics,
Features and Selling Princes of Leading Infectious Disease
Automated and Semi-automated Analyzers
C. Emerging Infectious Disease Diagnostic Technologies
1. Molecular Diagnostics
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Others
D. Personal Testing
III. Country Analyses: Sales and Volume Forecasts
IV. Major Product Development Opportunities
A. Instrumentation
B. Reagent Kits and Test Systems/Panels
C. Information Technology
D. Auxiliary Products
V. Design Criteria for Decentralized Testing Products
VI. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
VII. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
VIII. Competitive Assessments
- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix
- DiaSorin
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Fujirebio
- Grifols
- GSK Biologicals
- Hologic
- Leica Biosystems
- Lonza
- Ortho-Clinical Diagnostics
- PerkinElmer
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens Healthineers
- Takara Bio
- Thermo Fisher
- Wako
List Of Tables
GLOBAL RUBELLA TESTING MARKETMajor Companies Developing or Marketing Septicemia Tests
France
Septicemia Test Volume and Diagnostics Sales Forecast
By Market Segment
France
Septicemia Testing Market Diagnostics Sales
By Major Supplier
Germany
Septicemia Test Volume and Diagnostics Sales Forecast
By Market Segment
Germany
Septicemia Testing Market Diagnostics Sales
By Major Supplier
Italy
Septicemia Test Volume and Diagnostics Sales Forecast
By Market Segment
Italy
Septicemia Testing Market Diagnostics Sales
By Major Supplier
Japan
Septicemia Test Volume and Diagnostics Sales Forecast
By Market Segment
Japan
Septicemia Testing Market Diagnostics Sales
By Major Supplier
Spain
Septicemia Test Volume and Diagnostics Sales Forecast
By Market Segment
List of Tables (continued)
Spain
Septicemia Testing Market Diagnostics Sales
By Major Supplier
U.K.
Septicemia Test Volume and Diagnostics Sales Forecast
By Market Segment
U.K.
Septicemia Testing Market Diagnostics Sales
By Major Supplier
U.S.A.
Septicemia Test Volume and Diagnostics Sales Forecast
By Market Segment
U.S.A.
Septicemia Testing Market Diagnostics Sales
By Major Supplier
Global Neuromodulation Devices Market Outlook 2021: Global Opportunity and Demand Analysis, Market Forecast to 2030
The neuromodulation devices market is anticipated to grow at a CAGR of 6.5% over the forecast period of 20202028. According to a study published by Insure Insights on the neuromodulation
USD 3950 View ReportGlobal Neuromarketing Solutions Market Outlook 2021: Global Opportunity and Demand Analysis, Market Forecast, 2022-2030
The Global Neuromarketing Solutions market is anticipated to rise at a value CAGR of 9.65% over 20202028. According to a study published by Insure Insights on the Global Neuromarketing Solutions
USD 3950 View Report2024 Global Respiratory Disease Testing Market
2024 Global Respiratory Disease Testing Market: Unmet Needs, Supplier Shares and Strategies, Segment Volume and Sales Forecasts for Major Assays, Emerging Technologies and Trends, Instrumentation Pipeline, Growth Opportunities for Suppliers
USD 7500 View ReportGlobal Respiratory Disease Diagnostics Market 2023-2029
The global respiratory disease diagnostics market is likely to register a CAGR of over 7.7% with an incremental growth of USD 4.4 billion during the forecast period 2023-2029.The report covers
USD 3050 View ReportFill The Form For Sample Request